SENS vs. TRNS, CTKB, LAB, EYPT, AEHR, ALNT, QTRX, QSI, NAUT, and KEQU
Should you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Allient (ALNT), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry.
Senseonics vs.
Transcat (NASDAQ:TRNS) and Senseonics (NYSE:SENS) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability.
Transcat has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500.
Transcat currently has a consensus price target of $130.25, suggesting a potential upside of 29.81%. Senseonics has a consensus price target of $2.00, suggesting a potential upside of 135.88%. Given Senseonics' stronger consensus rating and higher possible upside, analysts clearly believe Senseonics is more favorable than Transcat.
Transcat has a net margin of 6.63% compared to Senseonics' net margin of -362.30%. Transcat's return on equity of 7.36% beat Senseonics' return on equity.
In the previous week, Senseonics had 2 more articles in the media than Transcat. MarketBeat recorded 6 mentions for Senseonics and 4 mentions for Transcat. Transcat's average media sentiment score of 0.44 beat Senseonics' score of 0.18 indicating that Transcat is being referred to more favorably in the media.
98.3% of Transcat shares are owned by institutional investors. Comparatively, 12.4% of Senseonics shares are owned by institutional investors. 2.3% of Transcat shares are owned by company insiders. Comparatively, 3.6% of Senseonics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Transcat received 207 more outperform votes than Senseonics when rated by MarketBeat users. Likewise, 66.88% of users gave Transcat an outperform vote while only 8.33% of users gave Senseonics an outperform vote.
Transcat has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
Summary
Transcat beats Senseonics on 13 of the 18 factors compared between the two stocks.
Get Senseonics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Senseonics Competitors List
Related Companies and Tools
This page (NYSE:SENS) was last updated on 1/21/2025 by MarketBeat.com Staff
Free SENS Stock Alerts